Advancing Supportive Patient CareSupportive Care Products
Improving the recovery and quality of life for cancer treatment patients
DARA is a supportive care specialty pharmaceutical company with a portfolio of unique and synergistic oncology products
DARA BioSciences
DARA is a specialty pharmaceutical company dedicated to the commercialization of oncology treatment and oncology supportive care products. DARA has significant opportunity for growth by leveraging its expanding portfolio of unique and synergistic products.
Supportive Care Focus
DARA is identifying and commercializing speciality products to help cancer patients feel better and recover more quickly.
Product Portfolio
Recent News
- May 15, 2013 DARA Reports First Quarter 2013 Financial Results and Operational Highlights
- Apr 22, 2013 DARA and HELSINN Announce U.S. Launch of Gelclair(R), an FDA-Cleared Oral Gel for the Treatment of Oral Mucositis
- Apr 3, 2013 DARA BioSciences Enters Into Distribution Agreement for Gelclair(R) and Soltamox(R) With Prime Therapeutics Specialty Pharmacy